These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35138583)

  • 1. Evaluation of a predictive model of end-stage kidney disease in a French-based cohort.
    Ingwiller M; Krummel T; Dimitrov Y; Muller C; Ott J; Chantrel F; Klein A; Hannedouche T;
    Int Urol Nephrol; 2022 Sep; 54(9):2335-2342. PubMed ID: 35138583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of End-Stage Kidney Disease Using Estimated Glomerular Filtration Rate With and Without Race : A Prospective Cohort Study.
    Bundy JD; Mills KT; Anderson AH; Yang W; Chen J; He J;
    Ann Intern Med; 2022 Mar; 175(3):305-313. PubMed ID: 35007146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia.
    Wang Y; Nguyen FNHL; Allen JC; Lew JQL; Tan NC; Jafar TH
    BMC Nephrol; 2019 Dec; 20(1):451. PubMed ID: 31801468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing vascular access planning in CKD: validating the 40% KFRE threshold for predicting ESKD in a French retrospective cohort study.
    Ingwiller M; Keller N; Krummel T; Prinz E; Steinmetz L; Hannedouche T; Florens N
    Clin Kidney J; 2024 Aug; 17(8):sfae220. PubMed ID: 39421238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the kidney failure risk equation in predicting the risk of progression to kidney failure in a multi-ethnic Singapore chronic kidney disease cohort.
    Kwek JL; Pang HQJ; Li H; Lim WWL; Choo JCJ; Choong HL; Foo MWY; Chan CM
    Singapore Med J; 2022 Jun; 63(6):313-318. PubMed ID: 36043308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study.
    Major RW; Shepherd D; Medcalf JF; Xu G; Gray LJ; Brunskill NJ
    PLoS Med; 2019 Nov; 16(11):e1002955. PubMed ID: 31693662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of end-stage kidney disease risk prediction in an ethnically diverse cohort of people with type 2 diabetes: use of kidney failure risk equation.
    Goubar A; Mangelis A; Thomas S; Fountoulakis N; Collins J; Ayis S; Karalliedde J
    BMJ Open Diabetes Res Care; 2024 Sep; 12(4):. PubMed ID: 39277182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the kidney failure risk equation in a Portuguese cohort.
    da Silva BM; Charreu J; Duarte I; Outerelo C; Gameiro J
    Nefrologia (Engl Ed); 2023; 43(4):467-473. PubMed ID: 36529658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A validation study of the kidney failure risk equation in advanced chronic kidney disease according to disease aetiology with evaluation of discrimination, calibration and clinical utility.
    Ali I; Donne RL; Kalra PA
    BMC Nephrol; 2021 May; 22(1):194. PubMed ID: 34030639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Kidney Failure Risk Equation in Manitoba.
    Whitlock RH; Chartier M; Komenda P; Hingwala J; Rigatto C; Walld R; Dart A; Tangri N
    Can J Kidney Health Dis; 2017; 4():2054358117705372. PubMed ID: 28491341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gout and the risk of advanced chronic kidney disease in the UK health system: a national cohort study.
    Stack AG; Johnson ME; Blak B; Klein A; Carpenter L; Morlock R; Maguire AR; Parsons VL
    BMJ Open; 2019 Aug; 9(8):e031550. PubMed ID: 31462487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CKD stage-specific utility of two equations for predicting 1-year risk of ESKD.
    Zheng S; Parikh RV; Tan TC; Pravoverov L; Patel JK; Horiuchi KM; Go AS
    PLoS One; 2023; 18(11):e0293293. PubMed ID: 37910454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of the corticomedullary difference in magnetic resonance imaging-derived apparent diffusion coefficient for noninvasive assessment of chronic kidney disease in type 2 diabetes.
    Duan S; Geng L; Lu F; Chen C; Jiang L; Chen S; Zhang C; Huang Z; Zeng M; Sun B; Zhang B; Mao H; Xing C; Zhang Y; Yuan Y
    Diabetes Metab Syndr; 2024 Feb; 18(2):102963. PubMed ID: 38373384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prediction model on incident ESKD among individuals with T2D and CKD.
    Lin Y; Shao H; Fonseca V; Anderson AH; Batuman V; Shi L
    J Diabetes Complications; 2023 Apr; 37(4):108450. PubMed ID: 36871314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies.
    Minutolo R; Gabbai FB; Chiodini P; Provenzano M; Borrelli S; Garofalo C; Bellizzi V; Russo D; Conte G; De Nicola L;
    Am J Kidney Dis; 2020 Jan; 75(1):30-38. PubMed ID: 31409508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the kidney failure risk equation in European CKD patients.
    Peeters MJ; van Zuilen AD; van den Brand JA; Bots ML; Blankestijn PJ; Wetzels JF;
    Nephrol Dial Transplant; 2013 Jul; 28(7):1773-9. PubMed ID: 23645476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Histologic Parameters to Predict Glomerular Disease Progression: Findings From the China Kidney Biopsy Cohort Study.
    Zhang X; Luo F; Chen R; Shen J; Liu X; Shi Y; Yang Q; Huang T; Li H; Hu Y; Wan Q; Chen C; Jia N; Cao Y; Li Y; Zhao H; Su L; Gao P; Xu X; Nie S; Hou FF
    Am J Kidney Dis; 2023 Apr; 81(4):416-424.e1. PubMed ID: 36252881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
    Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
    Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.